nuclear medicine

nuclear medicine
Name	Nuclear Medicine
Caption	A gamma camera used in SPECT imaging.
MeshID	D009683

nuclear medicine is a medical specialty that uses radioactive substances, known as radiopharmaceuticals, for diagnosis and therapy. The field uniquely combines principles from physics, chemistry, and biology to visualize physiological processes within the body. Its diagnostic applications primarily involve imaging techniques like PET and SPECT, while therapeutic uses deliver targeted radiation to treat specific diseases. The practice is governed by stringent international safety standards overseen by bodies such as the International Atomic Energy Agency.

Overview

The fundamental principle involves administering radiopharmaceuticals, which accumulate in specific organs or tissues based on their biochemical properties. Detection is achieved using specialized equipment like gamma cameras or PET scanners, which capture the emitted radiation to create functional images. This functional imaging contrasts with anatomical modalities like CT or MRI, providing complementary information on metabolism and physiology. Pioneering work by scientists like Georges Charpak and the development of instruments at institutions like CERN have been instrumental in advancing detection technology.

Diagnostic applications

Diagnostic imaging is the most widespread application, with PET scans being particularly vital in oncology for staging cancers like lung cancer and lymphoma. Common PET radiopharmaceuticals include FDG, a glucose analog. SPECT is extensively used in cardiology for myocardial perfusion imaging, often employing tracers like Tc-99m sestamibi. In neurology, these techniques assess conditions such as Alzheimer's disease and Parkinson's disease. Other specialized studies include renal scans using agents like DMSA and bone scans to detect metastases, utilizing tracers like Tc-99m medronate.

Therapeutic applications

Therapeutic applications deliver targeted radiation to destroy diseased tissue, primarily in oncology and endocrinology. A cornerstone treatment is radioiodine therapy using I-131 for hyperthyroidism and thyroid cancer, a practice advanced by work at the Massachusetts General Hospital. For pain relief from bone metastases, agents like Sr-89 or Sm-153 lexidronam are used. More recently, targeted radionuclide therapies have emerged, such as Lu-177 dotatate for neuroendocrine tumors and Ra-223 dichloride for prostate cancer. These treatments are often developed through collaborations between pharmaceutical companies like Novartis and research centers.

Radiopharmaceuticals

Radiopharmaceuticals are compounds consisting of a radioactive isotope bound to a targeting molecule. Their production requires specialized facilities, often cyclotrons for positron emitters like F-18, or nuclear reactors for isotopes like Mo-99, the parent of Tc-99m. The Tc-99m generator, pioneered by Walter Tucker and Henry Wagner Jr., revolutionized the field by providing a reliable source of this versatile isotope. Quality control is paramount and adheres to strict pharmacopoeial standards set by organizations like the United States Pharmacopeia. Research into new agents is ongoing at institutions like the Brookhaven National Laboratory.

Safety and regulation

Safety protocols are rigorous due to the use of radioactive materials. Radiation exposure for patients and staff follows the ALARA principle, guided by dose limits recommended by the International Commission on Radiological Protection. Regulatory oversight in the United States is shared by the Nuclear Regulatory Commission and the Food and Drug Administration. Globally, the International Atomic Energy Agency promotes safe practices and provides guidance. Waste disposal of radioactive materials is strictly controlled under regulations like those in the Euratom Treaty. Professional societies, including the Society of Nuclear Medicine and Molecular Imaging, establish practice guidelines.

History and development

The discovery of radioactivity by Henri Becquerel and Marie Curie in the late 19th century laid the foundation. The first therapeutic use is credited to Hermann Blumgart in 1925, who used radon to measure circulation time. The invention of the gamma camera by Hal Anger in the 1950s at the University of California, Berkeley was a transformative event. The subsequent development of CT by Godfrey Hounsfield and Allan Cormack inspired the creation of SPECT and PET, with major contributions from scientists like Michel Ter-Pogossian and Edward Hoffman. The awarding of the Nobel Prize in Chemistry to Georges Charpak in 1992 further highlighted the field's technological innovations.

Category:Medical specialties Category:Radiology